All Articles by Author:
Jamie Kang
Muscle Cell News
NCOR1 Maintains the Homeostasis of Vascular Smooth Muscle Cells and Protects against Aortic Aneurysm
[Cell Death & Differentiation] By utilizing smooth muscle NCOR1 knockout mice, scientists demonstrated that smooth muscle NCOR1 deficiency decreased expression of contractile genes, impaired stress fiber formation, and reduced synthesis of elastin and collagens, manifesting a degradative phenotype of vascular smooth muscle cells.
Muscle Cell News
Cellular Senescence Is Increased in Airway Smooth Muscle Cells of Elderly Asthmatics
[American Journal of Physiology-Lung Cellular and Molecular Physiology] Scientists studied lung tissues from elderly asthmatics to explore whether senescent airway muscle cells contributed to airway structural or functional changes. They found greater airway fibrosis and senescence-associated secretory phenotype components than age-matched and younger non-asthmatics that may contribute to airway remodeling.
Muscle Cell News
DN200434 Inhibits Vascular Smooth Muscle Cell Proliferation and Prevents Neointima Formation in Mice after Carotid Artery Ligation
[Endocrinology and Metabolism] Researchers investigated whether DN200434 inhibited proliferation and migration of vascular smooth muscle cells and mitochondrial oxidative phosphorylation, and subsequently suppressed neointima formation in a mouse carotid artery ligation model.
Muscle Cell News
The Role of the Dystrophin Glycoprotein Complex in Muscle Cell Mechanotransduction
[Communications Biology] The authors provide an up-to-date perspective on the dystrophin-glycoprotein complex (DGC). They discuss the relationship between muscle cell mechanics and function, as well as the recent research for a role of the DGC in mechanotransduction and maintaining biomechanical integrity of muscle cells.
Popular
Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development
[Creative Medical Technology Holdings, Inc. (BioSpace)] Creative Medical Technology Holdings, Inc. announced an expanded agreement with Greenstone Biosciences, Inc. to leverage atificial intelligence in further developing its human iPSC platform for diabetes treatment.
Streamlined Regulatory Documentation Accelerates Development of Next Generation Therapies
[Pluristyx] Pluristyx submitted a Type II Drug Master File (DMF) to the US FDA for its PluriBankâ„¢ CG (Clinical Grade) iPSC lines.
Atlas of Multilineage Stem Cell Differentiation Reveals TMEM88 as a Developmental Regulator of Blood Pressure
[Nature Communications] Scientists engineered barcoded iPSCs to generate an atlas of multilineage differentiation from pluripotency, encompassing an eight-day time course with modulation of WNT, BMP, and VEGF signaling pathways.